AKBA
USDAkebia Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$2.100
Máximo
$2.145
Mínimo
$2.070
Volume
4.47M
Fundamentos da empresa
Capitalização de mercado
563.4M
Setor
Drug Manufacturers - Specialty & Generic
País
United States
Estatísticas de negociação
Volume médio
4.04M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.